Traws Pharma receives Nasdaq delisting notice; will request hearing to regain compliance

Traws Pharma, Inc.

Received delisting determination from Nasdaq on Sept 24, 2024 for failing to maintain minimum $1 bid price.
Second compliance period ended Sept 23, 2024; company did not regain compliance despite extension.
Company intends to request a hearing before Nasdaq Hearings Panel by Oct 1, 2024 to stay delisting.
Stock currently trades above $1, but no assurance of regaining compliance or meeting other listing criteria.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.